OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced its financial results for the year ended December 31, 2009. The Company reported total revenues from continuing operations of $428 million for 2009 compared to revenues of $379 million for 2008, a 13% increase over the prior year. Total revenues from continuing operations for the three months ended December [...]
Continue reading " OSI Pharmaceuticals, Inc. Announces Year End 2009 Financial Results "










































